Exelixis Inc Earnings Per Share, Basic and Diluted
Exelixis Inc (EXEL) reported Earnings Per Share, Basic and Diluted of $0.12 per share for the 3-month period ending 2016-12-31, per its 10-K filed 2017-02-27.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2017-08-02
- Exelixis Inc earnings per share, basic and diluted for the quarter ending 2016-12-31 was $0.12.
- Exelixis Inc earnings per share, basic and diluted for the quarter ending 2016-09-30 was -$0.04.
- Exelixis Inc earnings per share, basic and diluted for the quarter ending 2016-06-30 was -$0.15.
- Exelixis Inc earnings per share, basic and diluted for the quarter ending 2016-03-31 was -$0.26.
- Exelixis Inc earnings per share, basic and diluted for fiscal 2016 was -$0.28.
- Exelixis Inc earnings per share, basic and diluted for fiscal 2015 was -$0.77.
- Exelixis Inc earnings per share, basic and diluted for fiscal 2014 was -$1.34.
- Exelixis Inc earnings per share, basic and diluted for fiscal 2013 was -$1.29.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 6 month as first filed | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 9 month as first filed | Earnings Per Share, Basic and Diluted 12 month | Earnings Per Share, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2016-12-31 | $0.12 10-K · filed 2017-02-27 | -$0.28 10-K · filed 2017-02-27 | ||||||
| 2016-09-30 | -$0.04 10-K · filed 2017-02-27 | -$0.19 derived: net income ÷ weighted average shares · filed 2017-11-01 | -$0.44 10-Q · filed 2016-11-03 | |||||
| 2016-06-30 | -$0.15 10-Q · filed 2017-08-02 | -$0.16 10-Q · filed 2016-08-03 | -$0.41 10-Q · filed 2017-08-02 | -$0.43 10-Q · filed 2016-08-03 | ||||
| 2016-03-31 | -$0.26 10-Q · filed 2017-05-01 | -$0.27 10-Q · filed 2016-05-04 | ||||||
| 2015-12-31 | -$0.18 10-K · filed 2017-02-27 | -$0.19 10-K · filed 2016-02-29 | -$0.77 10-K · filed 2017-02-27 | -$0.81 10-K · filed 2016-02-29 | ||||
| 2015-09-30 | -$0.21 10-K · filed 2017-02-27 | -$0.22 10-Q · filed 2015-11-10 | -$0.59 10-Q · filed 2016-11-03 | -$0.62 10-Q · filed 2015-11-10 | ||||
| 2015-06-30 | -$0.21 10-K · filed 2017-02-27 | -$0.22 10-Q · filed 2015-08-11 | -$0.40 10-Q · filed 2016-08-03 | |||||
| 2015-03-31 | -$0.17 10-K · filed 2017-02-27 | -$0.18 10-Q · filed 2015-04-30 | ||||||
| 2014-12-31 | -$0.30 10-K · filed 2016-02-29 | -$1.34 10-K · filed 2017-02-27 | -$1.38 10-K · filed 2015-03-02 | |||||
| 2014-09-30 | -$0.32 10-K · filed 2016-02-29 | -$1.09 10-Q · filed 2015-11-10 | ||||||
| 2014-06-30 | -$0.38 10-K · filed 2016-02-29 | -$0.77 10-Q · filed 2015-08-11 | ||||||
| 2014-03-31 | -$0.39 10-K · filed 2016-02-29 | |||||||
| 2013-12-31 | -$0.38 10-K · filed 2015-03-02 | -$1.29 10-K · filed 2017-02-27 | -$1.33 10-K · filed 2015-03-02 | |||||
| 2013-09-30 | -$0.36 10-K · filed 2015-03-02 | -$0.95 10-Q · filed 2014-11-04 | ||||||
| 2013-06-30 | -$0.34 10-K · filed 2015-03-02 | -$0.58 10-Q · filed 2014-07-31 | ||||||
| 2013-03-31 | -$0.24 10-K · filed 2015-03-02 | |||||||
| 2012-12-31 | -$0.28 10-K · filed 2014-02-20 | -$0.91 10-K · filed 2017-02-27 | -$0.92 10-K · filed 2015-03-02 | |||||
| 2012-09-30 | -$0.20 10-K · filed 2014-02-20 | -$0.63 10-Q · filed 2013-10-30 | ||||||
| 2012-06-30 | -$0.25 10-K · filed 2014-02-20 | -$0.43 10-Q · filed 2013-08-06 | ||||||
| 2012-03-31 | -$0.18 10-K · filed 2014-02-20 | |||||||
| 2011-06-30 | -$0.16 10-Q · filed 2012-08-02 | -$0.40 10-Q · filed 2012-08-02 | ||||||
| 2011-03-31 | -$0.24 10-Q · filed 2012-05-03 | |||||||
| 2010-12-31 | -$0.16 10-K · filed 2012-02-22 | |||||||
| 2010-09-30 | -$0.08 10-K · filed 2012-02-22 | |||||||
| 2010-06-30 | -$0.21 10-K · filed 2012-02-22 | |||||||
| 2010-03-31 | -$0.40 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |